Understanding and recognizing cardiac amyloidosis

JAAPA. 2020 Oct;33(10):16-20. doi: 10.1097/01.JAA.0000697236.11386.3a.

Abstract

Cardiac amyloidosis is an infiltrative abnormality that causes myocardial thickening and dysfunction. Historically, it has been underrecognized as a cause of heart failure and was often misdiagnosed. In the past decade, the cardiology community has improved the understanding of the subtypes of these protein-based infiltrates and how they play a role in heart failure. This article reviews the pathophysiology, presentation, diagnosis, and management of cardiac amyloidosis.

Publication types

  • Review

MeSH terms

  • Amyloid Neuropathies, Familial
  • Amyloidosis / diagnosis*
  • Amyloidosis / etiology
  • Amyloidosis / pathology
  • Amyloidosis / therapy*
  • Cardiomyopathies / diagnosis*
  • Cardiomyopathies / etiology
  • Cardiomyopathies / pathology
  • Cardiomyopathies / therapy*
  • Diagnosis, Differential
  • Diagnostic Errors / prevention & control
  • Echocardiography
  • Heart Failure / etiology
  • Humans
  • Immunoglobulin Light Chains
  • Immunoglobulin Light-chain Amyloidosis
  • Myocardium / pathology
  • Prealbumin

Substances

  • Immunoglobulin Light Chains
  • Prealbumin

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related